Adeno-Associated Virus Vectors: Principles, Practices, and Prospects in Gene Therapy

Area of Science:

• Molecular Biology
• Biotechnology
• Genetics

Background:

• Gene therapy offers a promising approach for treating genetic conditions by correcting mutations.
• Adeno-associated viruses (AAVs) are highly efficient, versatile, and safe vectors for gene delivery.
• AAVs are at the forefront of gene therapy, with numerous clinical trials and approved products.

Purpose of the Study:

• To review the evolution and current applications of AAVs in gene therapy.
• To highlight clinical successes, ongoing developments, and manufacturing processes for AAV therapies.
• To discuss the implications of AAV advancements for future therapeutic strategies and challenges.

Main Methods:

• Literature review of AAV gene therapy evolution, clinical trials, and applications.
• Analysis of AAV manufacturing processes and market growth.
• Exploration of future therapeutic strategies and challenges in the field.

Main Results:

• AAVs have demonstrated significant potential, evidenced by over 225 clinical trials.
• Six AAV-based gene therapy products have received FDA approval, underscoring their efficacy.
• The AAV therapy market anticipates rapid commercial growth, driven by ongoing developments.

Conclusions:

• AAVs are a cornerstone of modern gene therapy, with a proven track record of success.
• Continued advancements in AAV technology and manufacturing are crucial for expanding therapeutic applications.
• Addressing current challenges is essential for realizing the full potential of AAV-based treatments for complex diseases and aging.